The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

The FDA approves Vertex's non-opioid oral pain signal inhibitor, Journavx, for treating adults with moderate-to-severe acute pain. Shares rise.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The US Food and Drug Administration (FDA) announced its approval of a non-opioid treatment for moderate–severe acute chronic ...

Your feet can tell you a lot about your general health condition or warn you of underlying health conditions. From pesky foot ...

Oculis' main value driver appears to be OCS-01, which targets a respectable $4B DME TAM with its non-invasive eye drops. See ...

Are you an Ozempic user, or considering starting on the drug? You may want to read this. Recent research is cause for concern, suggesting a potential link between Ozempic and a serious eye condition ...

If you would like to learn how Regenerative Neuropathy can reverse your neuropathy symptoms without prescriptions or addictive medications, call 618-206-5924. Regenerative Neuropathy of O’Fallon ...

TUESDAY, Jan. 14, 2025 (HealthDay News) -- Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes, ...

The first selective Fatty Acid Binding Protein 5 inhibitor safely administered to human subjectsInitial safety and pharmacokinetic data expected ...

Our team looked at over 100 of the top auto insurance providers in the U.S., from national providers like USAA, Travelers and State Farm to regional providers like Erie Insurance. 8,500 Data ...

Lean diabetes (defined as those with a BMI level of under 25 and random blood glucose levels of over 200 requiring diabetic medication) may lead to more complications than diabetes among the obese, ...